Abstract

This is a Cancer Center Core support grant providing Core support for administration, program, and research efforts for the Los Angeles County/University of Southern California Comprehensive Cancer Center. This Center is one of the twenty-one designated comprehensive cancer centers in the United States. Cancer activities at this Center constitute one of the largest University-based cancer research and control efforts in the nation. Principal effort is focused in a Basic Research Program including activity in Chemical Carcinogenesis, Tumor and Cell Biology, Lymphocyte Biology and Immunology; in Clinical Cancer Investigations including Tumor Imaging, Radiopharmacy, Hematopathology, Clinical Immunology, Clinical Pathology; Surgery, Chemotherapy, Immunotherapy, Phase II and III Trials, and Clinical Pharmacology; in Biostatistical and Epidemiological studies of major import; and in an extensive Cancer Control Program reaching throughout the Southwestern United States. In addition, the Center conducts an extensive training and education program in the above specialty areas. The Center also acts as the Operations headquarters for the National Children's Cancer Study Group and as a member of several other cooperative groups. More than 200 faculty members and scientific investigators of the University and affiliated institutions are involved in this effort, with extramural funding for research, education during 1980.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-11
Application #
3101381
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1980-04-01
Project End
1987-11-30
Budget Start
1986-02-01
Budget End
1986-11-30
Support Year
11
Fiscal Year
1986
Total Cost
Indirect Cost

  Institution

Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033

  Publications

Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Basso, Virginia; Garcia, Angie; Tran, Dat Q et al. (2018) Fungicidal Potency and Mechanisms of ?-Defensins against Multidrug-Resistant Candida Species. Antimicrob Agents Chemother 62:
Austria, Theresa; Marion, Christine; Yu, Vanessa et al. (2018) Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways. Int J Cancer 143:2932-2942
Ning, Y; Zhang, W; Hanna, D L et al. (2018) Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients. Pharmacogenomics J 18:29-34
Battaglin, Francesca; Naseem, Madiha; Puccini, Alberto et al. (2018) Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int 18:99
Zhang, Junjie; Zhao, Jun; Xu, Simin et al. (2018) Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication. Cell Host Microbe 24:234-248.e5
Eriguchi, Yoshihiro; Nakamura, Kiminori; Yokoi, Yuki et al. (2018) Essential role of IFN-? in T cell-associated intestinal inflammation. JCI Insight 3:
Thomas, Nancy E; Edmiston, Sharon N; Orlow, Irene et al. (2018) Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. J Invest Dermatol 138:2398-2404
Cobo, Eduardo R; Holani, Ravi; Moreau, France et al. (2018) Entamoeba histolytica Alters ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun :
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clin Colorectal Cancer 17:e395-e414

Showing the most recent 10 out of 842 publications